Home › Funds › Citigroup Inc › FATE
Citigroup Inc position in FATE
FATE THERAPEUTICS INC COM · Health Care
Latest position (Q2 2026)19.63K sh
Reported value held$53.00K
Portfolio Weight0.00%
First reportedQ3 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 10.57K | $13.32K | Reduce |
| Q4 2025 | 27.46K | $26.98K | Add |
| Q1 2026 | 5.05K | $6.06K | Reduce |
| Q2 2026 | 19.63K | $53.00K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FATE
- Redmile Group, LLC 12.87M sh · $34.76M · Q2 2026
- BlackRock Inc 7.30M sh · $19.71M · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 4.55M sh · $12.27M · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 4.45M sh · $12.00M · Q2 2026
- AQR Capital Management 3.84M sh · $10.36M · Q2 2026
- AQR CAPITAL MANAGEMENT LLC 3.84M sh · $10.36M · Q2 2026
- Two Sigma Investments 3.59M sh · $9.69M · Q2 2026
- JOHNSON & JOHNSON 3.38M sh · $9.12M · Q2 2026
- Vanguard Group 8.97M sh · $8.82M · Q4 2025
- Renaissance Technologies 2.98M sh · $8.05M · Q2 2026
- Millennium Management 2.43M sh · $6.57M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 2.43M sh · $6.57M · Q2 2026